Updated Jul 16, 2026
Bitetti Teresa Marie has filed 3 SEC Form 4 filings across 2 companies in the last 90 days.

Teresa Marie Bitetti is a corporate executive currently serving as the President of the Oncology Business Unit (OBU) at Takeda Pharmaceutical Company Limited. She has been involved in the pharmaceutical industry, focusing on oncology and related therapeutic areas. Details about her early career and educational background are not widely available.
| Role | President, OBU |
|---|---|
| Notability | 20/100 |
| Date | Ticker | Company | Code | Shares | Price | Value |
|---|---|---|---|---|---|---|
| 2026-07-06 | TAK | TAKEDA PHARMACEUTICAL CO LTD | A — Grant or award | 43.9K | $0.00 | |
| 2026-06-15 | AURA | Aura Biosciences, Inc. | A — Grant or award | 15.0K | $0.00 | |
| 2026-04-28 | TAK | TAKEDA PHARMACEUTICAL CO LTD | A — Grant or award | 65.0K | $0.00 |
Teresa Marie Bitetti is a corporate executive currently serving as the President of the Oncology Business Unit (OBU) at Takeda Pharmaceutical Company Limited. She has been involved in the pharmaceutical industry, focusing on oncology and related therapeutic areas. Details about her early career and educational background are not widely available.…
3 primary Form 4 filings in the last 90 days, covering 2 companies.
All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.
Open the live Bitetti Teresa Marie profile on InsiderAlpha for real-time alerts, AI-scored trade ideas, and full transaction history.